Your session is about to expire
← Back to Search
Family Navigation for ADHD Treatment Adherence (I2-ART Trial)
I2-ART Trial Summary
This trial is testing a new intervention to improve treatment adherence in minority children with ADHD. The intervention will be compared to usual care to see if it is more effective.
I2-ART Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowI2-ART Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.I2-ART Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a healthcare provider for children with ADHD and am over 18.I am over 18 and care for a child with ADHD, who may or may not have started treatment.I am over 18, identify as Latinx or African American, and have experience as a family navigator or community health worker.I am over 18 years old.Some health professionals who currently treat children with ADHD are psychologists, general pediatricians, or developmental pediatricians.This exclusion criterion seems incomplete and does not provide enough information. Please provide more details or context.People of any race or ethnicity can participate.
- Group 1: I2-ART Group
- Group 2: Control Group
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the cap on how many participants are allowed for this trial?
"Affirmative, the clinicaltrials.gov site attests that this research project is in need of enrollees. It was initially posted on May 14th 2021 and has recently been updated on August 6th 2021. The study requires 108 individuals to be recruited at a single medical facility."
Are there any individuals who are eligible to participate in this trial at the present moment?
"Based on the details provided by clinicaltrials.gov, this study is in search of recruits and has been since it was first published on May 14th 2021. The information there was most recently refreshed as of August 6th 2021."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger